semaglutide after kidney transplant in patients with failure and obesity undergoing dialysis and wishing to be transplanted: A prospective, observational, open‐label study - Vanek - 2024 - Diabetes, Obesity and Metabolism Frontiers | Elective semaglutide prescription

Youre still driving, but now youve got a supportive navigator keeping you on course

The beneficial effects of single molecule GLP-1/Gcg coagonism were also demonstrated in ob/ob mice, which had enhanced GSIS and improved glucose tolerance upon acute treatment with a GLP-1/Gcg coagonist (Gault et al., 2013)

The Link to Chronic Disease This state of high alert doesnt just wear the system out

48 In patients with MASH-related cirrhosis and severe portal hypertension, emricasan could not improve either HVPG or clinical outcomes (NCT02960204)

Future studies should explore these complex factors to develop more effective prevention and treatment strategies for better disease management goals